Shigeki Makino
Takatsuki, 5698686, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Radiological diversity in rheumatoid arthritis associated with usual interstitial pneumonia (RA-UIP) and its therapeutic implications: towards a generalizable framework of interstitial lung disease treatment.
Journal: Respiratory research
Published: January 13, 2026
The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
Published: December 08, 2021
2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease.
Journal: Respiratory investigation
Published: April 07, 2021
Pre-pregnancy serum complement C3 level is a predictor of preterm birth for pregnancies with systemic lupus erythematosus.
Journal: Arthritis research & therapy
Published: March 15, 2021
Efficacy and safety of nintedanib in Japanese patients with progressive fibrosing interstitial lung diseases: Subgroup analysis of the randomised, double-blind, placebo-controlled, phase 3 INBUILD trial.
Journal: Respiratory medicine
Published: March 04, 2021
Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.
Journal: Modern rheumatology
Published: September 23, 2020
Development of central retinal artery occlusion accompanied by choroidal folds in a patient with antineutrophil cytoplasmic antibody-associated vasculitis: A case report.
Journal: Medicine
Published: September 03, 2020
Evaluation of poor prognostic factors of respiratory related death in microscopic polyangiitis complicated by interstitial lung disease.
Journal: Scientific reports
Published: June 09, 2020
Nintedanib in patients with systemic sclerosis-associated interstitial lung disease: A Japanese population analysis of the SENSCIS trial.
Journal: Modern rheumatology
Published: April 04, 2020
Exploration of pathomechanism using comprehensive analysis of serum cytokines in polymyositis/dermatomyositis-interstitial lung disease.
Journal: Rheumatology (Oxford, England)
Published: April 18, 2019
Correction: Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.
Journal: PloS one
Published: January 31, 2019
Last Updated: 09/26/2026